Furthermore, dominantly inherited PLCG2 mutations have been documented to cause autoimmunity and inflammation (designated as PLAID for PLCγ2-associated antibody deficiency and immune dysregulation and as APLAID for autoinflammation, antibody deficiency, and immune dysregulation). The gene discussed is PLCG2; the disease is agammaglobulinemia.